Brainsway Ltd ADR (BWAY)

$14.66 -0.83 (-5.36%)
Market Cap 621.63M
Revenue (ttm) 52.23M
Net Income (ttm) 7.58M
EPS (ttm) N/A
PE Ratio 37.09
Forward PE 47.30
Profit Margin 14.51%
Debt to Equity Ratio 0.00
Volume 113,100
Avg Vol 126,702
Day's Range N/A - N/A
Shares Out 40.13M
Stochastic %K 5%
Beta 1.24
Analysts Strong Sell
Price Target $18.60

Company Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitat...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 2 582 4030
Address:
16 Hartum St, Har Hotzvim, Jerusalem, Israel
JimmyOcarri
JimmyOcarri Aug. 17 at 9:22 PM
$RTB $IMUX $BWAY $LVLU q
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:33 PM
$NCEW $RTB $CCG $IMUX $BWAY gem---
0 · Reply
Synaptric
Synaptric Aug. 13 at 12:40 PM
Yesterday's double-digit moves came from the full range of sentiment scores. $NBIS $WYFI $EAT $BWAY $JMIA up while LQDA fell.
0 · Reply
Estimize
Estimize Aug. 12 at 10:09 PM
$BWAY reported 0.07 EPS and 17.11 revenue for Q2. http://www.estimize.com/intro/bway?chart=historical&metric_name=eps&utm_content=BWAY&utm_
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 12 at 11:39 AM
$BWAY Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.07 up 40.00% YoY • Reported revenue of $17.11M up 35.43% YoY • BrainsWay now expects full-year 2026 revenue of $68 million to $70 million, operating income between 13.5% and 14% of revenue, and Adjusted EBITDA of $13 million to $14 million for the period.
0 · Reply
speculator
speculator Aug. 12 at 11:35 AM
$STIM clinic biz on fire, even before psychedelics roll out and $CMPS partnership financial impact. But device biz also inflecting, with 10% underlying growth and the largest installed base in the US. Seems like a good time to remember $STIM trades at less than 1.5x revenue while peer $BWAY trades at 9x, despite smaller US installed base.
0 · Reply
Doozio
Doozio Aug. 12 at 12:28 AM
Can $BWAY continue to $ASND thru da $$$$ wen they all report eps ONTO 🐒🍌🧠⏰♾️
0 · Reply
_ProfessorGamma
_ProfessorGamma Aug. 9 at 6:52 PM
$BWAY Better footing than before
0 · Reply
BioTuesdays
BioTuesdays Jul. 20 at 4:23 PM
BTIG initiated coverage on two companies with “buy” ratings that it believes are undervalued players in the transcranial magnetic stimulation (TMS) space. Analyst Sam Eiber assigns target prices of $5 to Neuronetics $STIM and $18 to BrainsWay $BWAY https://biotuesdays.com/2026/07/20/btig-starts-coverage-of-two-tms-companies-at-buy-sees-anticipated-psilocybin-therapy-approval-as-potential-catalyst-for-both/
0 · Reply
EZ_Money11
EZ_Money11 Jul. 20 at 11:36 AM
$BWAY 📰🗞️
0 · Reply
Latest News on BWAY
Brainsway (BWAY) Upgraded to Buy: Here's Why

2026-08-17T16:00:03.000Z - 1 day ago

Brainsway (BWAY) Upgraded to Buy: Here's Why

Brainsway reports Q2 EPS 7c, consensus 7c

2026-08-17T09:48:48.000Z - 2 days ago

Brainsway reports Q2 EPS 7c, consensus 7c

Brainsway raises FY26 revenue view to $68M-$70M from $66M-$68M

2026-08-17T09:48:05.000Z - 2 days ago

Brainsway raises FY26 revenue view to $68M-$70M from $66M-$68M

Brainsway price target raised to $18.80 from $18 at Ladenburg

2026-08-17T07:58:16.000Z - 2 days ago

Brainsway price target raised to $18.80 from $18 at Ladenburg

Brainsway Q2 Earnings Call Highlights

Thu, 13 Aug 2026 05:03:41 -0400 - 6 days ago

Brainsway Q2 Earnings Call Highlights

BrainsWay Earnings Call Transcript: Q2 2026

Aug 13, 2026, 4:00 AM EDT - 6 days ago

BrainsWay Earnings Call Transcript: Q2 2026

BrainsWay Earnings release: Q2 2026

Aug 13, 2026, 4:00 AM EDT - 6 days ago

BrainsWay Earnings release: Q2 2026

BrainsWay Ltd (BWAY) Shares Surge 11.0% -- What GF Score of 58 Tells Investors

2026-08-13T01:04:34.000Z - 6 days ago

BrainsWay Ltd (BWAY) Shares Surge 11.0% -- What GF Score of 58 Tells Investors

BrainsWay Releases Q2 2026 Financial Results

2026-08-12T12:29:38.000Z - 7 days ago

BrainsWay Releases Q2 2026 Financial Results

BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights

Wed, 12 Aug 2026 07:30:00 -0400 - 7 days ago

BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights

Earnings To Watch: BrainsWay Ltd (BWAY) Q2 2026 -- GF Value Sees 35% Downside

2026-08-11T13:20:45.000Z - 8 days ago

Earnings To Watch: BrainsWay Ltd (BWAY) Q2 2026 -- GF Value Sees 35% Downside

Brainsway and Lululemon athletica have been highlighted as Zacks Bull and Bear of the Day

2026-07-24T11:19:00.000Z - 26 days ago

Brainsway and Lululemon athletica have been highlighted as Zacks Bull and Bear of the Day

Bull of the Day: Brainsway (BWAY)

2026-07-24T08:30:00.000Z - 26 days ago

Bull of the Day: Brainsway (BWAY)

Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway

2026-07-21T09:03:00.000Z - 4 weeks ago

Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway

BrainsWay Ltd (BWAY) Stock Up 4.9% but GF Value Says Overvalued -- GF Score: 65/100

2026-07-21T01:25:26.000Z - 4 weeks ago

BrainsWay Ltd (BWAY) Stock Up 4.9% but GF Value Says Overvalued -- GF Score: 65/100

4 Medical Products Stocks Poised to Win Despite Industry Headwinds

2026-07-20T18:11:00.000Z - 4 weeks ago

4 Medical Products Stocks Poised to Win Despite Industry Headwinds

BrainsWay Announces Strategic Investment in Radial Health, Inc.

Jul 20, 2026, 7:30 AM EDT - 4 weeks ago

BrainsWay Announces Strategic Investment in Radial Health, Inc.

BWAY

Brainsway initiated with a Buy at BTIG

2026-07-20T10:00:10.000Z - 4 weeks ago

Brainsway initiated with a Buy at BTIG

BWAY

BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral

Jul 16, 2026, 7:30 AM EDT - 4 weeks ago

BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral

BWAY

BrainsWay (BWAY) Shares Positive Results from Real-World Study on PTSD and Depression

2026-06-29T13:27:12.000Z - 7 weeks ago

BrainsWay (BWAY) Shares Positive Results from Real-World Study on PTSD and Depression

Brainsway presents new Deep Transcranial Magnetic Stimulation data

2026-06-29T11:46:25.000Z - 7 weeks ago

Brainsway presents new Deep Transcranial Magnetic Stimulation data

BWAY

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

Jun 29, 2026, 7:30 AM EDT - 7 weeks ago

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

BWAY

BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives

Jun 22, 2026, 7:30 AM EDT - 2 months ago

BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives

BWAY

BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting

Jun 9, 2026, 7:30 AM EDT - 2 months ago

BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting

BWAY

Brainsway price target raised to $17 from $15 at H.C. Wainwright

2026-05-26T10:16:13.000Z - 3 months ago

Brainsway price target raised to $17 from $15 at H.C. Wainwright

BWAY

Brainsway announces $1.5M investment in APS Innovations

2026-05-18T11:48:34.000Z - 3 months ago

Brainsway announces $1.5M investment in APS Innovations

BWAY

BrainsWay Announces Minority-Stake Investment in Hopemark Health

May 18, 2026, 7:30 AM EDT - 3 months ago

BrainsWay Announces Minority-Stake Investment in Hopemark Health

BWAY

Brainsway Q1 Earnings Call Highlights

Wed, 13 May 2026 10:08:23 -0400 - 3 months ago

Brainsway Q1 Earnings Call Highlights

BrainsWay Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

BrainsWay Earnings Call Transcript: Q1 2026

BrainsWay Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 3 months ago

BrainsWay Earnings release: Q1 2026

Brainsway reports Q1 EPS 6c, consensus 5c

2026-05-13T12:02:25.000Z - 3 months ago

Brainsway reports Q1 EPS 6c, consensus 5c

BWAY

Brainsway backs FY26 revenue view $66M-$68M, consensus $66.44M

2026-05-13T12:01:50.000Z - 3 months ago

Brainsway backs FY26 revenue view $66M-$68M, consensus $66.44M

BWAY

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

May 13, 2026, 7:30 AM EDT - 3 months ago

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

BWAY

BrainsWay Slides: Investor presentation

May 13, 2026, 7:00 AM EDT - 3 months ago

BrainsWay Slides: Investor presentation

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

Apr 29, 2026, 8:00 AM EDT - 4 months ago

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

BWAY

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Apr 15, 2026, 7:30 AM EDT - 4 months ago

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

BWAY

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

Apr 13, 2026, 8:00 AM EDT - 4 months ago

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

BWAY

Brainsway completes revenue-based milestone investment into Axis Integrated

2026-03-19T12:00:50.000Z - 5 months ago

Brainsway completes revenue-based milestone investment into Axis Integrated

BWAY

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

Mar 19, 2026, 7:30 AM EDT - 5 months ago

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

BWAY

BrainsWay Slides: Investor presentation

Mar 18, 2026, 8:00 AM EDT - 5 months ago

BrainsWay Slides: Investor presentation

Brainsway price target adjusted to $15 at H.C. Wainwright after ADS ratio change

2026-03-12T12:20:51.000Z - 5 months ago

Brainsway price target adjusted to $15 at H.C. Wainwright after ADS ratio change

BWAY

BrainsWay Earnings Call Transcript: Q4 2025

Mar 11, 2026, 8:30 AM EDT - 5 months ago

BrainsWay Earnings Call Transcript: Q4 2025

BrainsWay Earnings release: Q4 2025

Mar 11, 2026, 8:30 AM EDT - 5 months ago

BrainsWay Earnings release: Q4 2025

BrainsWay Annual report: Q4 2025

Mar 11, 2026, 8:30 AM EDT - 5 months ago

BrainsWay Annual report: Q4 2025

Brainsway reports Q4 EPS 7c, consensus 3c

2026-03-11T11:38:13.000Z - 5 months ago

Brainsway reports Q4 EPS 7c, consensus 3c

BWAY

Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M

2026-03-11T11:37:56.000Z - 5 months ago

Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M

BWAY

BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Mar 11, 2026, 7:30 AM EDT - 5 months ago

BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

BWAY

Brainsway announces new data on noninvasive way to treat depression

2026-03-04T12:50:32.000Z - 6 months ago

Brainsway announces new data on noninvasive way to treat depression

BWAY

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

Mar 4, 2026, 7:30 AM EST - 6 months ago

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

BWAY

BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

Feb 25, 2026, 8:00 AM EST - 6 months ago

BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

BWAY

Brainsway announces new minority-stake investment in BrainStim Health

2026-02-19T12:40:17.000Z - 6 months ago

Brainsway announces new minority-stake investment in BrainStim Health

BWAY

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

Feb 19, 2026, 7:30 AM EST - 6 months ago

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

BWAY

Brainsway says Cigna’s Evernorth to eliminate authorization requirement for TMS

2026-02-18T12:35:26.000Z - 6 months ago

Brainsway says Cigna’s Evernorth to eliminate authorization requirement for TMS

BWAY CI

BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

Wed, 18 Feb 2026 07:30:00 -0500 - 6 months ago

BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

Brainsway announces change in ADS-to-ordinary share ratio

2026-02-17T12:45:55.000Z - 6 months ago

Brainsway announces change in ADS-to-ordinary share ratio

BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

Tue, 17 Feb 2026 07:30:00 -0500 - 6 months ago

BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

Brainsway management to meet virtually with Northland

2026-02-10T20:10:23.000Z - 6 months ago

Brainsway management to meet virtually with Northland

Brainsway price target raised to $30 from $24 at H.C. Wainwright

2026-01-26T11:11:37.000Z - 7 months ago

Brainsway price target raised to $30 from $24 at H.C. Wainwright

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

Wed, 21 Jan 2026 07:30:00 -0500 - 7 months ago

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

BrainsWay Announces FDA Approval of Neurolief's Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

Jan 12, 2026, 7:30 AM EST - 7 months ago

BrainsWay Announces FDA Approval of Neurolief's Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™

Jan 7, 2026, 7:30 AM EST - 8 months ago

BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

Dec 22, 2025, 7:30 AM EST - 8 months ago

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

BrainsWay Transcript: Analyst & Investor Day 2025

Dec 1, 2025, 10:00 AM EST - 9 months ago

BrainsWay Transcript: Analyst & Investor Day 2025

BrainsWay Press release: FY 2025

Dec 1, 2025, 10:00 AM EST - 9 months ago

BrainsWay Press release: FY 2025

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025

Nov 25, 2025, 7:30 AM EST - 9 months ago

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

Nov 17, 2025, 7:30 AM EST - 9 months ago

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

Nov 13, 2025, 6:00 AM EST - 9 months ago

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

BrainsWay Slides: Investor Presentation

Nov 12, 2025, 7:00 AM EST - 10 months ago

BrainsWay Slides: Investor Presentation

BrainsWay Earnings Call Transcript: Q3 2025

Nov 11, 2025, 8:30 AM EST - 10 months ago

BrainsWay Earnings Call Transcript: Q3 2025

BrainsWay Earnings release: Q3 2025

Nov 11, 2025, 8:30 AM EST - 10 months ago

BrainsWay Earnings release: Q3 2025

BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 11, 2025, 7:30 AM EST - 10 months ago

BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder

Nov 4, 2025, 8:00 AM EST - 10 months ago

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 28, 2025, 8:00 AM EDT - 10 months ago

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

Oct 27, 2025, 7:30 AM EDT - 10 months ago

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

Aug 21, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

Aug 20, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

BrainsWay Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 1 year ago

BrainsWay Earnings Call Transcript: Q2 2025

BrainsWay Earnings release: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 1 year ago

BrainsWay Earnings release: Q2 2025

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

Aug 13, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Jun 11, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

Jun 10, 2025, 8:00 AM EDT - 1 year ago

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

Jun 4, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

BrainsWay Earnings Call Transcript: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Earnings Call Transcript: Q1 2025

BrainsWay Earnings release: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Earnings release: Q1 2025

BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights

May 13, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights

BrainsWay Registration statement: Registration Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

BrainsWay Registration statement: Registration Filing

BrainsWay Earnings Call Transcript: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Earnings Call Transcript: Q4 2024

BrainsWay Annual report: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Annual report: Q4 2024

BrainsWay Earnings release: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Earnings release: Q4 2024

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 11, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

Dec 12, 2024, 8:00 AM EST - 1 year ago

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

Nov 20, 2024, 8:00 AM EST - 1 year ago

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

BrainsWay Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

BrainsWay Earnings Call Transcript: Q3 2024

BrainsWay Earnings release: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

BrainsWay Earnings release: Q3 2024

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

Nov 12, 2024, 7:30 AM EST - 1 year ago

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

Oct 29, 2024, 8:00 AM EDT - 1 year ago

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

Oct 9, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

Sep 30, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

BrainsWay Announces Significant Expansion on U.S. East Coast

Sep 16, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Announces Significant Expansion on U.S. East Coast

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

Sep 10, 2024, 8:00 AM EDT - 2 years ago

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

BrainsWay Appoints Richard A. Bermudes, M.D.

Aug 29, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Appoints Richard A. Bermudes, M.D.

BrainsWay Earnings Call Transcript: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

BrainsWay Earnings Call Transcript: Q2 2024

BrainsWay Earnings release: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 2 years ago

BrainsWay Earnings release: Q2 2024

BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights

Aug 6, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 23, 2024, 8:00 AM EDT - 2 years ago

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

BrainsWay Registration statement: Registration Filing

Jul 22, 2024, 8:00 AM EDT - 2 years ago

BrainsWay Registration statement: Registration Filing

BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

Jun 17, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression

Jun 10, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression

JimmyOcarri
JimmyOcarri Aug. 17 at 9:22 PM
$RTB $IMUX $BWAY $LVLU q
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:33 PM
$NCEW $RTB $CCG $IMUX $BWAY gem---
0 · Reply
Synaptric
Synaptric Aug. 13 at 12:40 PM
Yesterday's double-digit moves came from the full range of sentiment scores. $NBIS $WYFI $EAT $BWAY $JMIA up while LQDA fell.
0 · Reply
Estimize
Estimize Aug. 12 at 10:09 PM
$BWAY reported 0.07 EPS and 17.11 revenue for Q2. http://www.estimize.com/intro/bway?chart=historical&metric_name=eps&utm_content=BWAY&utm_
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 12 at 11:39 AM
$BWAY Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.07 up 40.00% YoY • Reported revenue of $17.11M up 35.43% YoY • BrainsWay now expects full-year 2026 revenue of $68 million to $70 million, operating income between 13.5% and 14% of revenue, and Adjusted EBITDA of $13 million to $14 million for the period.
0 · Reply
speculator
speculator Aug. 12 at 11:35 AM
$STIM clinic biz on fire, even before psychedelics roll out and $CMPS partnership financial impact. But device biz also inflecting, with 10% underlying growth and the largest installed base in the US. Seems like a good time to remember $STIM trades at less than 1.5x revenue while peer $BWAY trades at 9x, despite smaller US installed base.
0 · Reply
Doozio
Doozio Aug. 12 at 12:28 AM
Can $BWAY continue to $ASND thru da $$$$ wen they all report eps ONTO 🐒🍌🧠⏰♾️
0 · Reply
_ProfessorGamma
_ProfessorGamma Aug. 9 at 6:52 PM
$BWAY Better footing than before
0 · Reply
BioTuesdays
BioTuesdays Jul. 20 at 4:23 PM
BTIG initiated coverage on two companies with “buy” ratings that it believes are undervalued players in the transcranial magnetic stimulation (TMS) space. Analyst Sam Eiber assigns target prices of $5 to Neuronetics $STIM and $18 to BrainsWay $BWAY https://biotuesdays.com/2026/07/20/btig-starts-coverage-of-two-tms-companies-at-buy-sees-anticipated-psilocybin-therapy-approval-as-potential-catalyst-for-both/
0 · Reply
EZ_Money11
EZ_Money11 Jul. 20 at 11:36 AM
$BWAY 📰🗞️
0 · Reply
prismmarketview
prismmarketview Jul. 17 at 12:44 PM
#BrainsWay (NASDAQ: $BWAY ) is continuing its “clinic‑partner” expansion strategy with a new $500K minority‑stake investment in Sound Minds Behavioral, an outpatient behavioral health provider, using preferred equity with milestone options to widen access to Deep TMS across another frontline mental‑health network. #MentalHealth #BehavioralHealth #Depression #DeepTMS https://prismmarketview.com/companies/brainsway-ltd/#news
0 · Reply
Estimize
Estimize Jul. 9 at 11:03 AM
Wall St is expecting 0.08 EPS for $BWAY Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/bway?chart=historical&metric_name=eps&utm_co
0 · Reply
prismmarketview
prismmarketview Jun. 29 at 8:38 PM
$BWAY presented positive real-world data from a 462-patient study showing its Deep TMS technology achieved an 83.5% response rate in patients with comorbid PTSD and major depressive disorder. https://prismmarketview.com/companies/brainsway-ltd/#news
0 · Reply
jpurr
jpurr Jun. 25 at 3:54 PM
$BWAY
0 · Reply
WallStWireAds
WallStWireAds Jun. 22 at 9:01 PM
$DRTS https://thefinanceherald.com/a-brain-cancer-win-got-the-headlines-this-small-cap-has-four-more-cancers-in-the-clinic-nasdaq-drts/ $ORMP $BWAY
2 · Reply
prismmarketview
prismmarketview Jun. 22 at 7:11 PM
@BrainsWay ($BWAY) reports that favorable insurance coverage for its accelerated Deep TMS protocols has climbed to over 57 million covered lives, expanding access to its noninvasive neuromodulation treatment and strengthening the commercial case for this emerging mental health tech name. https://prismmarketview.com/companies/brainsway-ltd/#news
0 · Reply
oattias10
oattias10 Jun. 22 at 12:16 PM
$BWAY announced that reimbursement coverage for its SWIFT accelerated Deep TMS protocol has expanded, reaching a cumulative opportunity of more than $57 million. Separately, BrainsWay recently reported that more than 80% of patients treated with the SWIFT protocol remained in remission at 12 months. If confirmed in a peer-reviewed publication with transparent reporting of patient follow-up and missing data, this would represent an exceptional outcome—well above the established benchmarks for any currently available depression treatment modality. This is amazing!
0 · Reply
focafoca99
focafoca99 Jun. 22 at 12:09 PM
$BWAY gained coverage for its Accelerated Deep TMS protocol across 57 million lives.
0 · Reply
Estimize
Estimize Jun. 11 at 11:03 AM
Wall St is expecting 0.05 EPS for $BWAY Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/bway?chart=historical&metric_name=eps&utm_co
0 · Reply